Alzheimer's disease: are blood and brain markers related? A systematic review

Plasma Gelsolin is Decreased and Correlates with Rate of Decline in Alzheimer's Disease

(2017) Andreas Güntert et al.   JOURNAL OF ALZHEIMERS DISEASE

Proteome-Based Plasma Markers of Brain Amyloid-β Deposition in Non-Demented Older Individuals

(2017) Madhav Thambisetty et al.   JOURNAL OF ALZHEIMERS DISEASE

Establishment and Dysfunction of the Blood-Brain Barrier

(2015) Zhen Zhao et al.   CELL

Blood-Brain Barrier Breakdown in the Aging Human Hippocampus

(2015) Axel Montagne et al.   NEURON

Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology

(2014) Martina Sattlecker et al.   Alzheimers & Dementia

Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo

(2014) Mingming Zhang et al.   Scientific Reports

Heat Shock Protein 70 in Alzheimer’s Disease

(2014) Rui-Chun Lu et al.   Biomed Research International

Proteomic analysis of postsynaptic density in Alzheimer's Disease

(2013) Jianying Zhou et al.   CLINICA CHIMICA ACTA

Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease

(2013) Michelle A Erickson et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study

(2013) S C Burnham et al.   MOLECULAR PSYCHIATRY

2′,3′-cyclic nucleotide phosphodiesterase (CNPase) as a target in neurodegenerative diseases

(2013) Yu. L. Baburina et al.   Neurochemical Journal

Differential Expression of Proteins in Brain Regions of Alzheimer’s Disease Patients

(2013) Saadia Zahid et al.   NEUROCHEMICAL RESEARCH

Neuroinflammatory Phenotypes and Their Roles in Alzheimer's Disease

(2013) Donna M. Wilcock   Neurodegenerative Diseases

U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease

(2013) B. Bai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical indications for analysis of Alzheimer's disease CSF biomarkers

(2013) S. Engelborghs   REVUE NEUROLOGIQUE

Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease

(2012) Holly D. Soares   ARCHIVES OF NEUROLOGY

Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease

(2012) James D. Doecke   ARCHIVES OF NEUROLOGY

Multidimensional plasma protein separation technique for identification of potential Alzheimer’s disease plasma biomarkers: a pilot study

(2012) Andreas Wolfram Henkel et al.   JOURNAL OF NEURAL TRANSMISSION

Label-Free Quantitative LC–MS Proteomics of Alzheimer’s Disease and Normally Aged Human Brains

(2012) Victor P. Andreev et al.   JOURNAL OF PROTEOME RESEARCH

Quantitative Proteomic Analysis of Human Substantia Nigra in Alzheimer’s Disease, Huntington’s Disease and Multiple Sclerosis

(2012) Sheng Chen et al.   NEUROCHEMICAL RESEARCH

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

(2012) W. T. Hu et al.   NEUROLOGY

Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease

(2012) Maria Björkqvist et al.   PLoS One

Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden

(2012) Steven John Kiddle et al.   PLoS One

Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease

(2012) Laura E. Donovan et al.   Proteomics Clinical Applications

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs

(2011) Salvatore Salomone et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Serum Levels of Pregnancy Zone Protein are Elevated in Presymptomatic Alzheimer’s Disease

(2011) Linda IJsselstijn et al.   JOURNAL OF PROTEOME RESEARCH

Human Alzheimer’s disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry

(2010) Yuliya V. Skorobogatko et al.   AMINO ACIDS

Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease

(2010) Madhav Thambisetty et al.   ARCHIVES OF GENERAL PSYCHIATRY

A Serum Protein–Based Algorithm for the Detection of Alzheimer Disease

(2010) Sid E. O’Bryant   ARCHIVES OF NEUROLOGY

Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer’s disease

(2009) Madhav Thambisetty et al.   JOURNAL OF NEUROLOGY

Relationships between biomarkers in aging and dementia

(2009) W. J. Jagust et al.   NEUROLOGY

The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone

(2008) Emma L. Akuffo et al.   BIOMARKERS

Disease State, Age, Sex, and Post-Mortem Time-Dependent Expression of Proteins in AD vs. Control Frontal Cortex Brain Samples

(2008) T. Muller et al.   Current Alzheimer Research

Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma

(2008) Paul Cutler et al.   Proteomics Clinical Applications

Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium

(2007) Timothy R. Mhyre et al.   NEUROBIOLOGY OF AGING